Table 1 Lab investigations between control and case groups

Urea

13.19 ± 2.44

13 (11–15.5)

157.45 ± 89.49

140 (100–200)

< 0.001^(M)

S

Creatinine

0.75 ± 0.09

0.7 (0.7–0.8)

5.42 ± 3.43

4.7 (2.8–6.6)

< 0.001^(M)

S

Uric acid

4.67 ± 0.52

4.5 (4.1–5.2)

9.75 ± 8.56

8 (6.8–11.55)

< 0.001^(M)

S

ALT

19.15 ± 2.51

18 (17–23)

92.85 ± 209.27

28 (15–73)

< 0.001^(M)

S

AST

19.92 ± 5.32

20 (15–23)

119.41 ± 258.76

37 (23–98)

< 0.001^(M)

S

Hb

12.84 ± 0.69

9.4 ± 2.62

< 0.001

S

WBCs (× 10₃)

5.91 ± 1

6.4 (5.4–6.7)

14.46 ± 16.44

12.5 (8.2–17.2)

< 0.001^(M)

S

Platelet (× 10₃)

349.73 ± 55.85

341 (312–399)

206.16 ± 130.21

184 (103–290)

< 0.001^(M)

S

Fasting glucose mg/dl

89.19 ± 4.14

98.37 ± 7.13

< 0.001

S

Fasting insulin level

18.19 ± 1.04

52.54 ± 15.81

< 0.001

S

Homatest IR

4.01 ± 0.28

12.73 ± 3.89

< 0.001

S

CRP (mg/dl)

0.83 ± 0.59

0.75 (0.3–1.2)

94.51 ± 102.77

56 (25–127)

< 0.001^(M)

S

Alb/cr in urine

8.27 ± 1.17

7.9 (7.8–8.9)

27.4 ± 20.56

22.4 (8.5–44.7)

< 0.001^(M)

S

Flow mediated dilatation of the brachial artery

11.67 ± 1.26

7.31 ± 0.75

< 0.001

S